Hospital
Thedacare Regional Medical Center - Appleton, INC
Thedacare Regional Medical Center - Appleton, INC was paid $834K by Medicaid between Jul 2022 and Dec 2024, across 87 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 17% of everything it billed.
33Billing provider infoTHEDACARE REGIONAL MEDICAL CENTER - APPLETON, INC
APPLETON, WI 54911
APPLETON, WI 54911
33aNPI1740920909assigned 03/29/2022
33bProvider typeGeneral Acute Care Hospital
28Total paid$834K
24GClaims64,373
24DCodes billed87
24AFirst – last monthJul 2022 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#44 of 60
Median peer was paid$2.90M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FLETT, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 8,246 | $80K | |
| 2023 | 27,266 | $328K | |
| 2024incomplete | 28,861 | $426K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 17% | 6,646 | 2,873 | $146K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 11% | 726 | 652 | $89K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 9.6% | 3,666 | 1,927 | $80K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.6% | 5,826 | 4,837 | $63K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.5% | 757 | 679 | $63K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5.5% | 3,037 | 1,341 | $46K |
| 96368 | 3.9% | 442 | 404 | $32K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 4,215 | 3,330 | $31K |
| 97162 | 3.6% | 804 | 751 | $30K | |
| 80061 | Lipid panel | 3.4% | 2,657 | 2,420 | $28K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.3% | 1,448 | 884 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.8% | 1,924 | 1,756 | $23K |
75 more codes
| 62323 | 2.4% | 119 | $20K | |
| 97163 | 2.4% | 686 | $20K | |
| 80076 | 2.2% | 2,424 | $18K | |
| 97113 | 1.8% | 388 | $15K | |
| 81025 | 1.3% | 894 | $11K | |
| 80306 | 1.2% | 611 | $10K | |
| 82947 | 1.0% | 1,168 | $9K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 81 | $6K |
| 62321 | <1% | 28 | $5K | |
| 85027 | <1% | 835 | $5K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 857 | $5K |
| 81001 | <1% | 770 | $4K | |
| 80053 | Comprehensive metabolic panel | <1% | 217 | $4K |
| C1776 | Joint device (implantable) | <1% | 154 | $4K |
| 97161 | <1% | 101 | $4K | |
| 64493 | <1% | 13 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 93 | $3K |
| 85651 | <1% | 350 | $3K | |
| 64483 | <1% | 14 | $3K | |
| 83735 | <1% | 391 | $2K | |
| 82043 | <1% | 367 | $2K | |
| 85610 | <1% | 483 | $2K | |
| 87631 | <1% | 15 | $2K | |
| 84460 | <1% | 343 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 145 | $1K |
| 82570 | <1% | 383 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 56 | $1K |
| 85014 | <1% | 62 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 56 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 55 | $937.53 |
| 82565 | <1% | 134 | $564.73 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $521.14 |
| 86140 | <1% | 53 | $250.47 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,317 | $246.24 |
| 77002 | <1% | 26 | $239.36 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 469 | $208.30 |
| 81003 | <1% | 121 | $196.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 387 | $183.08 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,854 | $150.36 |
| 87480 | <1% | 14 | $146.15 | |
| 99152 | <1% | 356 | $144.03 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 32 | $135.83 |
| 82728 | <1% | 15 | $123.35 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 934 | $115.65 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,616 | $110.82 |
| 85018 | <1% | 62 | $101.34 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,128 | $93.40 |
| 87510 | <1% | 14 | $65.95 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,666 | $62.88 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,087 | $48.29 |
| 87081 | <1% | 12 | $44.29 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 720 | $42.89 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 195 | $36.16 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 206 | $36.08 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,034 | $35.92 |
| 85652 | <1% | 13 | $34.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,322 | $32.76 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 675 | $26.91 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 146 | $23.33 |
| 73560 | <1% | 14 | $18.86 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 195 | $14.55 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 71 | $12.85 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 553 | $7.73 |
| J3490 | Unclassified drugs | <1% | 101 | $1.92 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 481 | $1.44 |
| 76000 | <1% | 12 | $0.32 | |
| 36592 | <1% | 61 | $0.13 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 826 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 625 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 0% | 334 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 15 | $0.00 |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | 0% | 111 | $0.00 |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | 0% | 19 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 13 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFLETT, WILLIAM (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.